(2021C) Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of Chronic Kidney Disease

Recorded On: 10/30/2021

  • Register
    • Non-member - $40
    • Member - $30
    • Resident/Fellow - $10
    • Student - $10

Completion of this activity will allow learners to explain the burden of chronic kidney disease; review the pathophysiology of diabetic nephropathy; recognize the mechanism of SGLT2 inhibitors in the management of CKD; evaluate the clinical trial data for SGLT2 inhibitors and renal outcomes; and summarize the role of SGLT2 inhibitors in clinical practice.  This program was originally recorded on October 30, 2021 at the ACOI's 2021 Annual Convention and Scientific Sessions.

Lubaina S. Presswala, DO

Board Certified Internal Medicine Physician

University Medical Center, Lubbock, TX

Key:

Complete
Failed
Available
Locked
Acknowledgement
Agree to terms to continue.
Agree to terms to continue.
Video
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin.
Post-Test
5 Questions  |  Unlimited attempts  |  80/100 points to pass
5 Questions  |  Unlimited attempts  |  80/100 points to pass
CME Certificate
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available